Relonchem

What Relonchem does

Relonchem Limited is a UK-based, independent generic pharmaceutical manufacturer and supplier founded in 2002, headquartered in Widnes, Cheshire. The company develops, manufactures, and distributes own-label generic pharmaceutical products across eight therapeutic areas — anti-diabetic, anti-hypertensive, anti-depressant, anti-cancer, anti-ulcerative, anti-viral, allergy relief, and pain relief — supplying UK pharmacies and pharmacy chains as its primary B2B customer base, with an additional international distribution channel supported by worldwide marketing authorisations. Its portfolio spans more than 100 generic products and is backed by over 400 product licences and 400+ marketing authorisations.

The company operates three integrated service lines: Product Development, Manufacturing, and Regulatory. Product development is centred on a state-of-the-art R&D laboratory staffed by over 50 scientists specialising in formulation development, analytical development, and stability studies, with capabilities covering sustained release, effervescent, semi-solid, and liquid dosage forms alongside novel drug delivery systems. Manufacturing is conducted at MHRA-approved facilities under GMP, producing tablets, capsules, and sachets. The regulatory function manages over 400 marketing authorisations covering more than 100 generic products globally. Commercial products observed in the catalogue include Aciclovir 5% w/w cream, Alendronic acid 70mg tablets, Azathioprine 50mg film-coated tablets, and Bicalutamide 150mg film-coated tablets.

RelonChem operates a sales-led B2B go-to-market with account-based onboarding ('Apply For An Account'), dedicated UK and international contact channels, and quote-based pricing that is not publicly disclosed. The business is privately held with no disclosed parent company, funding rounds, or institutional investors, and is reported as operating and actively maintained. No revenue figures, named customers, management biographies, or pricing tiers are publicly available, which constrains the visibility of its commercial scale.

Name

Relonchem

Legal name

Relonchem Limited

Website

https://relonchem.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

51–100 employees

Short description

Relonchem Limited is a UK-based independent generic pharmaceutical manufacturer and supplier founded in 2002, producing own-label tablets, capsules, and effervescent products across eight therapeutic areas for UK pharmacies and international distributors.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

Keywords

• Generic pharmaceutical manufacturing
• Own-label medication supply
• Pharmaceutical product development
• Regulatory affairs services
• Pharmaceutical contract manufacturing

Headquarters

HQ city

Widnes

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Generic Pharmaceutical Product Sales: RelonChem generates revenue through the sale of own-label generic pharmaceutical products. The company holds over 400 product licenses and marketing authorisations for more than 100 generic pharmaceutical products, supplying a broad range of medications including anti-diabetic, anti-hypertensive, anti-depressant, anti-cancer, anti-ulcerative, anti-viral, allergy relief, and pain relief medications to pharmacies and pharmacy chains in the UK.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Core offering

RelonChem is an independent generic pharmaceutical company that develops, manufactures, and supplies own-label generic pharmaceutical products to pharmacies and pharmacy chains in the UK and internationally. The portfolio covers eight therapeutic areas — anti-diabetic, anti-hypertensive, anti-depressant, anti-cancer, anti-ulcerative, anti-viral, allergy relief, and pain relief — and is backed by in-house Product Development, MHRA-approved GMP Manufacturing, and Regulatory services.

Product overview

RelonChem is an independent generic pharmaceutical company established in 2002 with over 400 product licences supplying own-label healthcare pharmaceutical products in the UK. The company operates across eight therapeutic areas: anti-diabetic, anti-hypertensive, anti-depressant, anti-cancer, anti-ulcerative, anti-viral, allergy relief, and pain relief medications. RelonChem provides three core services: Product Development (with a state-of-the-art R&D laboratory staffed by over 50 scientists specialising in formulation development, analytical development, and stability studies, creating sustained release products, effervescent products, semi-solids, liquids, and other drug delivery systems), Manufacturing (MHRA-approved facilities producing tablets, capsules, and sachets under GMP standards), and Regulatory services (managing over 400 Marketing Authorisations worldwide). The company's product portfolio includes Aciclovir 5% w/w Cream (antiviral), Alendronic acid 70mg Tablets (anti-diabetic/osteoporosis), Azathioprine 50mg Film-coated Tablets (immunosuppressant), and Bicalutamide 150mg Film-coated Tablets (anti-cancer), representing their generic pharmaceutical offerings across multiple therapeutic categories.

Differentiator

Problem solved

Functional benefit

Products and services

• Aciclovir 5% w/w Cream - 10g Topical antiviral cream containing 50mg Aciclovir per gram of cream, indicated for the treatment of Herpes simplex virus infections. Classified as POM (Prescription Only Medicine). Supplied as part of RelonChem's generic pharmaceutical portfolio to UK pharmacies and pharmacy chains.
• Alendronic acid 70mg Tablets x 4 Tablet medication indicated for the treatment of postmenopausal osteoporosis. Pack contains 4 tablets. Sold to UK pharmacies and pharmacy chains as part of RelonChem's generic pharmaceutical range.
• Azathioprine 50mg Film-coated Tablets x 100 Immunosuppressant medication used either alone or in combination with corticosteroids. Pack contains 100 film-coated tablets. Sold as a generic pharmaceutical product to UK pharmacies and pharmacy chains.
• Azathioprine 50mg Film-coated Tablets x 56 Immunosuppressant medication used either alone or in combination with corticosteroids. Pack contains 56 film-coated tablets. Sold as a generic pharmaceutical product to UK pharmacies and pharmacy chains.
• Bicalutamide 150mg Film-coated Tablets x 28 Anti-cancer medication used either alone or as adjuvant therapy to radical prostatectomy or radiotherapy in patients with locally advanced prostate cancer. Pack contains 28 film-coated tablets. Sold as a generic pharmaceutical product to UK pharmacies and pharmacy chains.
• Pharmaceutical Product Development Service R&D service delivered from RelonChem's state-of-the-art laboratory, staffed by over 50 scientists specialising in formulation development, analytical development, and stability studies. Develops sustained-release, effervescent, semi-solid, liquid, and other new drug delivery systems tailored to client specifications for pharmacies and pharmacy chains.
• Pharmaceutical Manufacturing Service Contract manufacturing service operated from MHRA-approved facilities under GMP protocols, producing tablets, capsules, and sachets to meet diverse customer and regulatory requirements. Available to pharmacies, pharmacy chains, and partner organisations.
• Regulatory Affairs Service Regulatory service managing over 400 marketing authorisations across more than 100 generic pharmaceutical products worldwide, ensuring product development, testing, and marketing adhere to global regulations.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Krka: Slovenian generic pharmaceutical manufacturer with an extensive portfolio across cardiovascular, diabetes, CNS, oncology, and other therapeutic areas, competing in the same UK/EU generic-pharmacy channels as RelonChem.
• Almus Pharmaceuticals: UK own-label generic pharmaceutical brand specifically created for pharmacy chains, with a directly comparable business model of supplying generic medicines to UK pharmacy groups.
• Ennogen Pharma: UK-based generic pharmaceutical manufacturer focused on own-label generics supplied through UK pharmacy and wholesale channels, with overlapping therapeutic categories and customer base.
• Accord Healthcare: UK-headquartered generic pharmaceutical manufacturer supplying the NHS and pharmacy chains across a broad portfolio of generic medicines — directly comparable to RelonChem in channel, customer base, and product type.
• Tillomed Laboratories: UK-based generic pharmaceutical company manufacturing and supplying generic medicines to UK pharmacies and wholesalers, with a similarly broad therapeutic-area footprint and own-label offering.
• Zentiva: European-headquartered generic pharmaceutical manufacturer with strong UK presence, producing generic medicines across multiple therapeutic areas — comparable in scale and European market focus to RelonChem.

Broad incumbents

• Viatris: Global healthcare company formed from Mylan and Upjohn, supplying a vast generic and established-brand portfolio to UK pharmacy and hospital channels in direct competition with RelonChem.
• Sandoz: Global generic and biosimilar pharmaceutical division of Novartis, with a much larger portfolio but overlapping directly with RelonChem across standard generic molecules supplied to UK pharmacies.
• Teva Pharmaceutical Industries: One of the world's largest generic pharmaceutical manufacturers with significant UK presence and a broad therapeutic-area portfolio that overlaps substantially with RelonChem's.
• Aurobindo Pharma: Indian-headquartered global generic pharmaceutical manufacturer with major UK and European supply, offering comparable generic molecules at scale and competing for the same pharmacy contracts.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/relonchem

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Relonchem